Showing results (691-700 of 767) with videos related to
Sort By:
Pageof 77
Abdominal Radiology (New York)|March 4, 2022
Pancreatic neuroendocrine neoplasms: a 2022 update for radiologistsSamuel J Galgano, Ajaykumar C Morani, Dheeraj R Gopireddy, et al.Journal of Diabetes|April 14, 2026
Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled StudyBrij Mohan, S Vasanth Kumar, Prakash Harishchandra Kurmi, et al.JMIR Public Health and Surveillance|April 30, 2020
Rates and Correlates of HIV Incidence in Namibia's Zambezi Region From 2014 to 2016: Sentinel, Community-Based Cohort StudyAndrew D Maher, Tuli Nakanyala, Nicholus Mutenda, et al.Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging, Fergus V Coakley, Aytekin Oto, et al.Nature Methods|May 1, 2025
ATLAS: a rationally designed anterograde transsynaptic tracerJacqueline F Rivera, Haoyang Huang, Weiguang Weng, et al.Science Advances|November 14, 2025
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiologySzu-Chi Liao, Kohei Kano, Sadhna Phanse, et al.Molecular and Cellular Biology|May 13, 2015
Spindle Checkpoint Factors Bub1 and Bub2 Promote DNA Double-Strand Break Repair by Nonhomologous End JoiningMatthew Jessulat, Ramy H Malty, Diem-Hang Nguyen-Tran, et al.Journal of Anxiety Disorders|February 28, 2026
Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative studyKalmegh Prabhakar, Gopalakrishnan Ganesan, Dhananjay Chaudhari, et al.Cancer Cell|July 9, 2014
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitorsSadhna R Vora, Dejan Juric, Nayoon Kim, et al.Nature Communications|January 13, 2021
Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complexKamran Rizzolo, Angela Yeou Hsiung Yu, Adedeji Ologbenla, et al.Pageof 77